TECX → $79.38 by Feb 19, 2027.

DD: TECX (Tectonic Therapeutic, Inc.) NASDAQ | Healthcare | Biotech EXECUTIVE SUMMARY Tectonic Therapeutic (TECX) is a clinical-stage biotech developing novel GPCR-targeted biologics through its proprietary GEODe platform. The company presents a compelling risk/reward setup driven by a well-funded balance sheet and multiple near-term catalysts in large unaddressed markets. OVERVIEW Tectonic Therapeutic is headquartered in Watertown, Massachusetts with 51 employees. The company focuses on discovering and developing therapeutic proteins and antibodies that modulate G-protein coupled receptors (GPCRs), the most important …